Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients

Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 936-943

  Naganuma, Makoto ^a,b   Ichikawa, Hitoshi ^a   Inoue, Nagamu ^a   Kobayashi, Taku ^a   Okamoto, Susumu ^a   Hisamatsu, Tadakazu ^a   Kanai, Takanori ^a   Ogata, Haruhiko ^a   Iwao, Yasushi ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine A; Endoscopic activity index; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COLON HEMORRHAGE; COLONOSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; ENDOSCOPIC ACTIVITY INDEX; EXUDATE; FEMALE; HUMAN; INTESTINE EXAMINATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; COLONOSCOPY; CYCLOSPORINE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956895195     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0244-2     Document Type: Article

References (17)

1. SC Truelove LJ Witts 1955 Cortisone in ulcerative colitis. Final report on a therapeutic trial Br Med J 2 104 108 10.1136/bmj.2.4931.104
2. JH Baron AM Connell TG Kanaghinis JE Lennard-Jones AF Jones 1962 Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone Br Med J 2 441 443 1:STN:280:DyaF38%2Fgs1Ciug%3D%3D 10.1136/bmj.2.5302.441 13865152
3. S Lichtiger DH Present A Kornbluth I Gelernt J Bauer G Galler, et al. 1994 Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1841 1845 1:STN:280:DyaK2c3lsV2ltA%3D%3D 10.1056/ NEJM199406303302601 8196726 (Pubitemid 24188135)
4. G D'Haens L Lemmens K Geboes L Vandeputte F Van Acker L Mortelmans, et al. 2001 Intravenous cyclosporin versus intravenous glucocorticosteroids as a single therapy for severe attacks of ulcerative colitis Gastroenterology 120 1323 1329 10.1053/gast.2001.23983 11313301
5. F Svavoni U Bonassi F Bagnolo 1998 Effectiveness of cyclosporine in the treatment of refractory ulcerative colitis Gastroenterology 114 A1096 10.1016/S0016-5085(98)84455-7
6. G Van Assche G D'Haens M Noman S Vermeire M Hiele K Asnong, et al. 2003 Randomized double-blind comparison of 4 mg/kg/day versus 2 mg/kg/day intravenous cyclosporin in severe ulcerative colitis Gastroenterology 125 1025 1031 10.1016/S0016-5085(03)01214-9 14517785 (Pubitemid 37193449)
7. D Moskovitz G Van Assche B Maenhout J Arts M Ferrante S Vermeire, et al. 2006 Incidence of colectomy during long term follow up after cyclosporin-induced remission of severe ulcerative colitis Clin Gastroenterol Hepatol 4 760 765 1:CAS:528:DC%2BD28XmvVylsro%3D 10.1016/j.cgh.2006.04.001 16716758 (Pubitemid 43833506)
8. G Jarnerot E Hertervig I Friis-Liby L Blomquist P Karlén C Grännö, et al. 2005 Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study Gastroenterology 128 1805 1811 10.1053/j.gastro.2005.03.003 15940615 (Pubitemid 40824691)
9. G Van Assche S Vermeire P Rutgeerts 2008 Treatment of severe steroid refractory ulcerative colitis World J Gastroenterol 14 5508 5511 10.3748/wjg.14.5508 18810767
10. D Rachmilwitz 1989 Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial Br Med J 298 82 86 10.1136/bmj.298.6666.82
11. SGF Matts 1961 The value of rectal biopsy in the diagnosis of ulcerative colitis Q J Med 30 393 407 1:STN:280:DyaF38%2Fnt12iug%3D%3D 14471445
12. M Naganuma S Funakoshi A Sakuraba H Takagi N Inoue H Ogata, et al. 2004 Granulocytopheresis is useful as an alterative therapy for steroid refractory and dependent ulcerative colitis Inflamm Bowel Dis 10 251 257 10.1097/00054725-200405000-00012 15290920 (Pubitemid 38618255)
13. G D'Haens WJ Sandborn BG Feagan K Geboes SB Hanauer EJ Irvine, et al. 2007 A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 132 763 786 10.1053/j.gastro.2006.12.038 17258735
14. KW Schroeder WJ Tremaine DM Ilstrup 1987 Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study N Engl J Med 317 1625 1629 1:STN:280:DyaL1c%2FmsFOkuw%3D%3D 10.1056/NEJM198712243172603 3317057
15. LR Sutherland F Martin S Greer M Robinson N Greenberger F Saibil, et al. 1987 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis Gastroenterology 92 1894 1898 1:STN:280:DyaL2s7ptFKlsg%3D%3D 3569765
16. T Ando Y Nishio O Watanabe H Takahashi O Maeda K Ishiguro, et al. 2008 Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis World J Gastroenterol 14 2133 2138 10.3748/wjg.14.2133 18407585
17. W Cacheux P Seksik M Lemann P Marteau I Nion-Larmurier P Afchain, et al. 2008 Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis Am J Gastroenterol 103 637 642 1:CAS:528:DC%2BD1cXkslKmtb4%3D 10.1111/j.1572-0241.2007.01653.x 18047542 (Pubitemid 351405993)